EUVIMEDEUVIMED entdecken
Open Access

Infliximab Limits Injury in Myocardial Infarction

Christopher Livia iD, Sara Inglis iD, Ruben Crespo-Diaz iD, Skylar Rizzo iD, Ryan Mahlberg iD, Monique Bagwell iD, Matthew Hillestad iD, Satsuki Yamada iD, Dhivya Vadhana Meenakshi Siddharthan iD, Raman Deep Singh iD, Xing Li, D Kent Arrell iD und 8 weitere

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.123.032172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Christopher Livia und 19 weiteren Autor:innen. Beteiligte Einrichtung: Van Cleve Cardiac Regenerative Medicine Program Mayo Clinic Rochester MN USA. Hauptthemen laut MEDLINE: Infliximab, Ventricular Remodeling, Disease Models, Animal. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background The purpose of this study was to investigate a therapeutic approach targeting the inflammatory response and consequent remodeling from ischemic myocardial injury. Methods and Results Coronary thrombus aspirates were collected from patients at the time of ST‐segment–elevation myocardial infarction and subjected to array‐based proteome analysis. Clinically indistinguishable at myocardial infarction (MI), patients were stratified into vulnerable and resilient on the basis of 1‐year left ventricular ejection fraction and death. Network analysis from coronary aspirates revealed prioritization of tumor necrosis factor‐α signaling in patients with worse clinical outcomes. Infliximab, a tumor necrosis factor‐α inhibitor, was infused intravenously at reperfusion in a porcine MI model to assess whether infliximab‐mediated immune modulation impacts post‐MI injury. At 3 days after MI (n=7), infliximab infusion increased proregenerative M2 macrophages in the myocardial border zone as quantified by immunofluorescence (24.1%±23.3% in infliximab versus 9.29%±8.7% in sham; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InfliximabVentricular RemodelingDisease Models, AnimalAnimalsHumansMaleMiddle AgedFemaleST Elevation Myocardial InfarctionVentricular Function, LeftSwineAgedTumor Necrosis Factor-alphaStroke VolumeCoronary ThrombosisMyocardiumTroponin IMacrophages

Stichwörter der Autor:innen

TNFα inhibitionimmune modulationinfliximabmyocardial infarctionporcine model

Substanzen

InfliximabTumor Necrosis Factor-alphaTroponin I

Autor:innen und Institutionen

  • Van Cleve Cardiac Regenerative Medicine Program Mayo Clinic Rochester MN USA.
  • Mayo Clinic Alix School of Medicine Mayo Clinic Graduate School of Biomedical Sciences Rochester MN USA.
  • Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA.
  • Cardiovascular Division University of Minnesota Minneapolis MN USA.
  • Marriott Heart Disease Research Program Mayo Clinic Rochester MN USA.
  • Division of Geriatric & Gerontology Medicine Mayo Clinic Rochester MN USA.

ORCID-Profile: Christopher Livia, Sara Inglis, Ruben Crespo-Diaz, Skylar Rizzo, Ryan Mahlberg, Monique Bagwell, Matthew Hillestad, Satsuki Yamada, Dhivya Vadhana Meenakshi Siddharthan, Raman Deep Singh, D Kent Arrell, Tyra Witt, Abdallah El Sabbagh, Charanjit Rihal, Andre Terzic, Jozef Bartunek, Atta Behfar

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Livia, C., Inglis, S., Crespo-Diaz, R., Rizzo, S., Mahlberg, R., Bagwell, M., Hillestad, M., Yamada, S., Meenakshi Siddharthan, D. V., Singh, R. D., Li, X., Arrell, D. K., Stalboerger, P., Witt, T., El Sabbagh, A., Rihal, M., Rihal, C., Terzic, A., Bartunek, J., & Behfar, A. (2024). Infliximab Limits Injury in Myocardial Infarction. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.032172

Vancouver

Livia C, Inglis S, Crespo-Diaz R, Rizzo S, Mahlberg R, Bagwell M, et al. Infliximab Limits Injury in Myocardial Infarction. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.032172

BibTeX
@article{Livia2024,
  author = {Livia, Christopher and Inglis, Sara and Crespo-Diaz, Ruben and Rizzo, Skylar and Mahlberg, Ryan and Bagwell, Monique and Hillestad, Matthew and Yamada, Satsuki and Meenakshi Siddharthan, Dhivya Vadhana and Singh, Raman Deep and Li, Xing and Arrell, D Kent and Stalboerger, Paul and Witt, Tyra and El Sabbagh, Abdallah and Rihal, Munveer and Rihal, Charanjit and Terzic, Andre and Bartunek, Jozef and Behfar, Atta},
  title = {Infliximab Limits Injury in Myocardial Infarction},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.123.032172}
}
Kostenlos starten →